Pharma and biotech on a roll as drug approvals hit 18-year high

Pharma and biotech on a roll as drug approvals hit 18-year high

… * U.S. FDA approves 41 novel medicines in 2014 vs 27 in 2013. * New treatments for cancer and rare disease fuel rise. * High cost of new drugs leads to tensions with insurers. By Ben Hirschler. LONDON, Jan 1 (Reuters) – U.S. drug approvals in 2014

5
Like
Save

Comments

Write a comment

*